Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Synbioven Limited investment portfolio
Synbioven Limited has made numerous investments in companies such as Resurrect Bio, Scindo, and Colorifix within the Biotech sector.
unknown
Portfolio
7
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (7)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Bitrobius Genetics Ltd Bitrobius Genetics develops the Gentrafix™ platform, a plasmid‑based technology that delivers therapeutic DNA to every affected cell through intercellular transmission, aiming to treat genetic diseases, including those caused by mitochondrial gene mutations. The company targets the gene‑therapy market for diseases that currently have no effective treatments. | Healthcare & Life Sciences | Macclesfield | Confirmed | 2025-11-23 |
| Colorifix Limited COLORIFIX LIMITED develops a biological dyeing technology that uses genetically engineered bacteria to produce and fix pigments onto textiles, offering an eco-friendly alternative to traditional chemical-based dyeing processes. The company primarily targets the textile and fashion industry, including global brands and manufacturers, with additional partnerships in cosmetics and homewares. | Professional Services | Norwich | Confirmed | 2026-03-30 |
Shareholding changes (7)
Synbioven Limited's positions across portfolio companies2026
- PREFERENCE A 0 → 3,614
- SERIES B 71,684 → 87,365
Articles (2)
- 18 Jul 2026
- Resurrect Bio Secures Additional £1.6m in Series A Funding to Advance Sustainable Crop Protection28 Apr 2026Resurrect Bio